Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors in non-small cell lung cancer.
Feld R, Borges M, Giner V, Ginsberg R, Harper P, Klastersky J, Lacquet L, Paesmans M, Payne D, Rosell R, et al. Feld R, et al. Among authors: giner v. Lung Cancer. 1994 Nov;11 Suppl 3:S19-23. doi: 10.1016/0169-5002(94)91861-9. Lung Cancer. 1994. PMID: 7704508 Review. No abstract available.
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Borges M, Sculier JP, Paesmans M, Richez M, Bureau G, Dabouis G, Lecomte J, Michel J, Van Cutsem O, Schmerber J, Giner V, Berchier MC, Sergysels R, Mommen P, Klastersky J. Borges M, et al. Among authors: giner v. Lung Cancer. 1996 Dec;16(1):21-33. doi: 10.1016/s0169-5002(96)00609-5. Lung Cancer. 1996. PMID: 9017582
Induction therapy for stage III NSCLC: a consensus report.
Green MR, Ginsberg R, Ardizzoni A, Choi N, Darwish S, Fukuoka M, Giner V, Grunenwald D, Harper P, Kho S, et al. Green MR, et al. Among authors: giner v. Lung Cancer. 1994 Nov;11 Suppl 3:S9-10. doi: 10.1016/0169-5002(94)91858-9. Lung Cancer. 1994. PMID: 7704518 Review. No abstract available.
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J. Sculier JP, et al. Among authors: giner v. Lung Cancer. 1998 Dec;22(3):201-13. doi: 10.1016/s0169-5002(98)00089-0. Lung Cancer. 1998. PMID: 10048473
A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P. Sculier JP, et al. Among authors: giner v. Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31. Lung Cancer. 2018. PMID: 29496253 Clinical Trial.
A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
Berghmans T, Van Houtte P, Paesmans M, Giner V, Lecomte J, Koumakis G, Richez M, Holbrechts S, Roelandts M, Meert AP, Alard S, Leclercq N, Sculier JP. Berghmans T, et al. Among authors: giner v. Lung Cancer. 2009 May;64(2):187-93. doi: 10.1016/j.lungcan.2008.08.004. Epub 2008 Sep 19. Lung Cancer. 2009. PMID: 18804894 Clinical Trial.
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working Party.
Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: giner v. Lung Cancer. 2012 Sep;77(3):605-10. doi: 10.1016/j.lungcan.2012.04.020. Epub 2012 Jun 15. Lung Cancer. 2012. PMID: 22704426 Clinical Trial.
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Efremidis A, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: giner v. J Clin Oncol. 1998 Apr;16(4):1388-96. doi: 10.1200/JCO.1998.16.4.1388. J Clin Oncol. 1998. PMID: 9552042 Clinical Trial.
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Sculier JP, Paesmans M, Lecomte J, Van Cutsem O, Lafitte JJ, Berghmans T, Koumakis G, Florin MC, Thiriaux J, Michel J, Giner V, Berchier MC, Mommen P, Ninane V, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: giner v. Br J Cancer. 2001 Nov 16;85(10):1444-51. doi: 10.1054/bjoc.2001.2114. Br J Cancer. 2001. PMID: 11720426 Free PMC article. Clinical Trial.
81 results